Mark Frydenberg
Mark Frydenberg
Professor, Department of Surgery, Monash University
Verified email at
Cited by
Cited by
AL Murkies, G Wilcox, SR Davis
The Journal of Clinical Endocrinology & Metabolism 83 (2), 297-303, 1998
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
Enzalutamide with standard first-line therapy in metastatic prostate cancer
ID Davis, AJ Martin, MR Stockler, S Begbie, KN Chi, S Chowdhury, ...
New England Journal of Medicine 381 (2), 121-131, 2019
Local aromatase expression in human prostate is altered in malignancy
SJ Ellem, JF Schmitt, JS Pedersen, M Frydenberg, GP Risbridger
The Journal of Clinical Endocrinology & Metabolism 89 (5), 2434-2441, 2004
Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men
RI McLachlan, L O’Donnell, PG Stanton, G Balourdos, M Frydenberg, ...
The Journal of Clinical Endocrinology & Metabolism 87 (2), 546-556, 2002
Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones
RA Jarred, M Keikha, C Dowling, SJ McPherson, AM Clare, AJ Husband, ...
Cancer Epidemiology and Prevention Biomarkers 11 (12), 1689-1696, 2002
Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer
FS Dalais, A Meliala, N Wattanapenpaiboon, M Frydenberg, DAI Suter, ...
Urology 64 (3), 510-515, 2004
Sepsis and ‘superbugs’: should we favour the transperineal over the transrectal approach for prostate biopsy?
JP Grummet, M Weerakoon, S Huang, N Lawrentschuk, M Frydenberg, ...
BJU international 114 (3), 384-388, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancer
NE Martin, L Massey, C Stowell, C Bangma, A Briganti, A Bill-Axelson, ...
European urology 67 (3), 460-467, 2015
The role of magnetic resonance imaging in the diagnosis and management of prostate cancer
J Thompson, N Lawrentschuk, M Frydenberg, L Thompson, P Stricker, ...
BJU international 112, 6-20, 2013
Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 …
GM Duchesne, HH Woo, JK Bassett, SJ Bowe, C D'Este, M Frydenberg, ...
The Lancet Oncology 17 (6), 727-737, 2016
Investigations with FDG-PET scanning in prostate cancer show limited value for clinical practice
E Salminen, A Hogg, D Binns, M Frydenberg, R Hicks
Acta Oncologica 41 (5), 425-429, 2002
Gyrus™ bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up
WD Dunsmuir, JP McFarlane, A Tan, C Dowling, J Downie, J Kourambas, ...
Prostate Cancer and Prostatic Diseases 6 (2), 182-186, 2003
The metaplastic effects of estrogen on mouse prostate epithelium: proliferation of cells with basal cell phenotype
GP Risbridger, H Wang, M Frydenberg, G Cunha
Endocrinology 142 (6), 2443-2450, 2001
Prostatic cancer: role of color Doppler imaging in transrectal sonography.
AM Lavoipierre, RM Snow, M Frydenberg, D Gunter, G Reisner, PL Royce, ...
AJR. American journal of roentgenology 171 (1), 205-210, 1998
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ...
Nature communications 8 (1), 1-10, 2017
Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome
WS Cheng, M Frydenberg, EJ Bergstralh, JJ Larson-Keller, H Zincke
Urology 42 (3), 283-291, 1993
Active surveillance for prostate cancer: a narrative review of clinical guidelines
SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ...
Nature Reviews Urology 13 (3), 151, 2016
AP hase III trial to investigate the timing of radiotherapy for prostate cancer with high‐risk features: background and rationale of the Radiotherapy–Adjuvant Versus Early …
M Pearse, C Fraser‐Browne, ID Davis, GM Duchesne, R Fisher, ...
BJU international 113, 7-12, 2014
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi …
MS Hofman, N Lawrentschuk, RJ Francis, C Tang, I Vela, P Thomas, ...
The Lancet, 2020
The system can't perform the operation now. Try again later.
Articles 1–20